JAK2 Mutations in Chronic Myeloproliferative Neoplasm; Towards the Application of Personalized Treatments for Saudi Patients

Journals Menu

Follow SCIRP

ISSN Print: 2164-3180
ISSN Online: 2164-3199
www.scirp.org/journal/ojbd
E-mail: ojbd@scirp.org

"JAK2 Mutations in Chronic Myeloproliferative Neoplasm; Towards the Application of Personalized Treatments for Saudi Patients"
written by Mamdooh Gari, Fatin Al-Sayes, Farid Ahmed, Abdul Ali Peerzada, Adel Abuzenadah, Lubna S. Mira, Mohammed Al-Qahtani, Ashraf Dallol, Adeel Chaudhary, Mohammed Mahnashi, Ghazi Damanhouri,
published by Open Journal of Blood Diseases, Vol.2 No.2, 2012

has been cited by the following article(s):

[1]	Correlation of Thrombosis and Clinicohematological Parameters with JAK2V617F Mutation in Philadelphia-Negative CMPNs: A Study from India
	Journal of …, 2022

[2]	A single developing country's Hematology-Oncology Centre retrospective analysis of the Janus Kinase 2 V617F mutation in Philadelphia negative …
	2020

[3]	Polycythaemia Vera among Sudanese Patients with Special Emphasis on JAK2 Mutations
	2019

[1]	Correlation of Thrombosis and Clinicohematological Parameters with JAK2V617F Mutation in Philadelphia-Negative CMPNs: A Study from India Journal of Laboratory Physicians, 2022 DOI:10.1055/s-0042-1757230

[2]	Correlation of Thrombosis and Clinicohematological Parameters with JAK2V617F Mutation in Philadelphia-Negative CMPNs: A Study from India Journal of Laboratory Physicians, 2022 DOI:10.1055/s-0042-1757230

[3]	Correlation of Thrombosis and Clinicohematological Parameters with JAK2V617F Mutation in Philadelphia-Negative CMPNs: A Study from India Journal of Laboratory Physicians, 2022 DOI:10.1055/s-0042-1757230

Follow SCIRP